Effects of omega fatty acids on the short-term postprandial satiety related peptides in rats
Abstract
Abstract: We aimed to assess the effects of omega fatty acids on time depending on responses of satiety hormones. Sixty adult rats were randomly divided into 4 groups; linoleic acid (LA), α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) groups. For each fatty acid, the dose of 400 mg/kg was applied by oral gavage. Blood samples were taken after the 15, 30, 60 and 120 minutes. Ghrelin, cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), peptide YY (PYY), leptin and insulin hormones were analyzed by ELISA. We observed the significant increases (p<0.05) of the levels of CCK between n-3 (ALA, at 60th min; EPA, at 30th and 60th min and DHA, at 60 min) and n-6 (LA) supplemented rats. The highest GLP-1 levels were in ALA (0.70 ng/mL) and DHA (0.67 ng/mL) supplemented groups at 60th and 120th min indicating n-3 fatty acids efficiency on satiety compared to LA. It seems that ALA at 60th min and EPA at 120th min could provide the highest satiety effect with the highest insulin response, while the efficiency of LA supplementation on insulin-induced satiety diminished. The only significant change in AUC values among all hormones was in the CCK of the ALA group (p=0.004). The level of leptin increased in DHA and EPA supplemented rats (p=0.140). Our results showed that dietary omega fatty acids influenced the releasing of hormones in different ways possibly depending on chain length or saturation degree. Comprehensive studies need to be addressed for each fatty acid on satiety-related peptide hormones.
References
1 . Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289–95. https://doi.org/10.1038/nature05026
2 . Dietary fatty acid composition affects food intake and gut-brain satiety signaling in Senegalese sole (Solea senegalensis, Kaup 1858) larvae and post-larvae. Gen Comp Endocrinol. 2016;228:79–94. https://doi.org/10.1016/j.ygcen.2016.02.002
3 . Does omega-3 fatty acids supplementation affect circulating leptin levels? A systematic review and meta-analysis on randomized controlled clinical trials. Clin Endocrinol. 2015;82(2):221–8.
4 . Effects of dietary fat on appetite and energy intake in health and obesity – Oral and gastrointestinal sensory contributions. Physiol Behav. 2011;104(4):613–20. https://doi.org/10.1016/j.physbeh.2011.04.038
5 . Cholecystokinin decreases food intake in rats1. Obes Res. 1997;5(3):284–90. https://doi.org/10.1002/j.1550-8528.1997.tb00305.x
6 , Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med. 2001;226(11):963–77. https://doi.org/10.1177/153537020122601102
7 The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut. 2000;46(5):688–93.
8 Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Integr Comp Physiol. 2004;287(3):R524–33. https://doi.org/10.1152/ajpregu.00039.2004
9 . The degree of saturation of fatty acids influences post-ingestive satiety. Br J Nutr. 2000;83(5):473–82.
10 . Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. 1999;116(1):46–53.
11 . Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132(6):2131–2157. https://doi.org/10.1053/j.gastro.2007.03.054
12 . Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept. 2008;149(1):70–8.
13 . The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368(9548):1696–705.
14 Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes. 1999;23(3):304–11. https://doi.org/10.1038/sj.ijo.0800818
15 . Leptin: Regulation and clinical applications. Leptin Regul Clin Appl. 2015;2:1–287.
16 . Metabolic status regulates ghrelin function on energy homeostasis. Neuroendocrinology. 2011;93(1):48–57.
17 . Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr. 2004;134(2):295–8. https://doi.org/10.1093/jn/134.2.295
18 . Central nervous system control of food intake. Nature. 2000;404(6778):661–71. https://doi.org/10.1038/35007534
19 Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production. Nature. 2008;452(7190):1012–6. https://doi.org/10.1038/nature06852
20 . Fats and fatty acid requirements for adults. Ann Nutr Metab. 2009;55(1–3):56–75.
21 . Intake of fatty acids in general populations worldwide does not meet dietary recommendations to prevent coronary heart disease: A systematic review of data from 40 countries. Ann Nutr Metab. 2013;63(3):229–38.
22 Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome. Obes Sci Pract. 2016;2(3):318–29. https://doi.org/10.1002/osp4.50
23 Dietary free oleic and linoleic acid enhances neutrophil function and modulates the inflammatory response in rats. Lipids. 2010;45(9):809–19. https://doi.org/10.1007/s11745-010-3461-9
24 . Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006;1088(1):83–92.
25 . Effect of fat saturation on satiety, hormone release, and food intake. Am J Clin Nutr. 2009;89(4):1019–24.
26 . A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite. 2008;51(3):676–80.
27 Fat-induced heal brake in humans: A dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology. 1993;105(3):733–9.
28 Effect of different long-chain fatty acids on cholecystokinin release in vitro and energy intake in free-living healthy males. Br J Nutr. 2012;108(4):755–8.
29 . Omega-3 fatty acids and obesity. J Food Nutr Disord. 2012;1:01.
30 . Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome. Clin Sci. 2008;114(3):183–93. https://doi.org/10.1042/CS20070115
31 . Relationship between central and peripheral fatty acids in humans. Lipids Health Dis. 2013;12(1):79. https://doi.org/10.1186/1476-511X-12-79
32 . Altered gut and adipose tissue hormones in overweight and obese individuals: Cause or consequence. Int J Obes. 2016;40(4):622–32. https://doi.org/10.1038/ijo.2015.220
33 The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes. 2015;39(3):424–9. https://doi.org/10.1038/ijo.2014.153
34 . Duodenal fatty acid sensor and transporter expression following acute fat exposure in healthy lean humans. Clin Nutr. 2017;36(2):564–9.
35 . Effects of long- and short-chain fatty acids on the release of gastrointestinal hormones using an ex vivo porcine intestinal tissue model. J Agric Food Chem. 2012;60(36):9035–42.
36 . Usefulness of colon targeted DHA and EPA as novel diabetes medications that promote intrinsic GLP-1 secretion. J Control Release. 2008;132(2):99–104.
37 Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. Peptides. 2006;27(7):1638–43.
38 Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men. Am J Clin Nutr. 2008;87(5):1181–7. https://doi.org/10.1093/ajcn/87.5.1181
39 . Free fatty acid-induced peptide YY expression is dependent on TG synthesis rate and Xbp1 splicing. Int J Mol Sci. 2020;21(9):3368.
40 Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects. Diabetes. 2003;52(3):675–681.
41 Inhibition of food intake in obese subjects by peptide YY3–36. N Engl J Med. 2003;349(10):941–8. https://doi.org/10.1056/NEJMoa030204
42 . Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985;89(5):1070–7.
43 . Hunger and satiety responses to high-fat meals after a high-polyunsaturated fat diet: A randomized trial. Nutrition. 2017;41:14–23.
44 . Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia. 2002;45(11):1533–41. https://doi.org/10.1007/s00125-002-0964-9
45 . The degree of fat saturation does not alter glycemic, insulinemic or satiety responses to a starchy staple in healthy men. J Nutr. 2003;133(8):2577–80. https://doi.org/10.1093/jn/133.8.2577
46 Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS One. 2012;7(1):e30571.
47 . Safflower (n-6) and flaxseed (n-3) high-fat diets differentially regulate hypothalamic fatty acid profiles, gene expression, and insulin signalling. Prostaglandins Leukot Essent Fat Acids. 2018;128:67–73.
48 . A chronic high fat diet alters the homologous and heterologous control of appetite regulating peptide receptor expression. Peptides. 2013;46:150–8.
49 . Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels. Nutr Res. 2009;29(11):768–76.
50 . Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr. 2013;67:1234–42. https://doi.org/10.1038/ejcn.2013.197
51 . Systematic review of marine-derived omega-3 fatty acid supplementation effects on leptin, adiponectin, and the leptin-to-adiponectin ratio. Nutr Res. 2021;85:135–52.
52 . Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Metab. 2005;289(6):E948–53. https://doi.org/10.1152/ajpendo.00220.2005
53 . Gastrointestinal regulation of food intake. J Clin Invest. 2007;117(1).